NDC 84141-025 – Redemplo

Plozasiran 25 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC84141-025

Product details

Brand name
Redemplo
Generic name
Plozasiran
Labeler
Arrowhead Pharmaceuticals, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA219947
Marketed since
November 19, 2025
Listing expires
December 31, 2027
Pharmacologic class
APOC-III-directed RNA Interaction; Small Interfering RNA

Active ingredients

Uses, dosage, side effects and warnings for Redemplo →

Package NDC codes (1)

Package NDCDescriptionSince
84141-025-011 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASSNov 19, 2025